An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein

SARS-CoV-2, responsible for the COVID-19 pandemic, invades host cells via its spike protein, which includes critical binding regions, such as the receptor-binding domain (RBD), the S1/S2 cleavage site, the S2 cleavage site, and heptad-repeat (HR) sections. Peptides targeting the RBD and HR1 inhibit...

Full description

Bibliographic Details
Main Authors: Chian Ho, Wan Fahmi Wan Mohamad Nazarie, Ping-Chin Lee
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/9/1930
_version_ 1797576447028625408
author Chian Ho
Wan Fahmi Wan Mohamad Nazarie
Ping-Chin Lee
author_facet Chian Ho
Wan Fahmi Wan Mohamad Nazarie
Ping-Chin Lee
author_sort Chian Ho
collection DOAJ
description SARS-CoV-2, responsible for the COVID-19 pandemic, invades host cells via its spike protein, which includes critical binding regions, such as the receptor-binding domain (RBD), the S1/S2 cleavage site, the S2 cleavage site, and heptad-repeat (HR) sections. Peptides targeting the RBD and HR1 inhibit binding to host ACE2 receptors and the formation of the fusion core. Other peptides target proteases, such as TMPRSS2 and cathepsin L, to prevent the cleavage of the S protein. However, research has largely ignored peptides targeting the S1/S2 cleavage site. In this study, bioinformatics was used to investigate the binding of the S1/S2 cleavage site to host proteases, including furin, trypsin, TMPRSS2, matriptase, cathepsin B, and cathepsin L. Peptides targeting the S1/S2 site were designed by identifying binding residues. Peptides were docked to the S1/S2 site using HADDOCK (High-Ambiguity-Driven protein–protein DOCKing). Nine peptides with the lowest HADDOCK scores and strong binding affinities were selected, which was followed by molecular dynamics simulations (MDSs) for further investigation. Among these peptides, BR582 and BR599 stand out. They exhibited relatively high interaction energies with the S protein at −1004.769 ± 21.2 kJ/mol and −1040.334 ± 24.1 kJ/mol, respectively. It is noteworthy that the binding of these peptides to the S protein remained stable during the MDSs. In conclusion, this research highlights the potential of peptides targeting the S1/S2 cleavage site as a means to prevent SARS-CoV-2 from entering cells, and contributes to the development of therapeutic interventions against COVID-19.
first_indexed 2024-03-10T21:52:03Z
format Article
id doaj.art-fb536ebbac3d4e5ca00c162c2c8dda09
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T21:52:03Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-fb536ebbac3d4e5ca00c162c2c8dda092023-11-19T13:23:43ZengMDPI AGViruses1999-49152023-09-01159193010.3390/v15091930An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike ProteinChian Ho0Wan Fahmi Wan Mohamad Nazarie1Ping-Chin Lee2Faculty of Science and Natural Resources, Universiti Malaysia Sabah, Kota Kinabalu 88400, Sabah, MalaysiaFaculty of Science and Natural Resources, Universiti Malaysia Sabah, Kota Kinabalu 88400, Sabah, MalaysiaFaculty of Science and Natural Resources, Universiti Malaysia Sabah, Kota Kinabalu 88400, Sabah, MalaysiaSARS-CoV-2, responsible for the COVID-19 pandemic, invades host cells via its spike protein, which includes critical binding regions, such as the receptor-binding domain (RBD), the S1/S2 cleavage site, the S2 cleavage site, and heptad-repeat (HR) sections. Peptides targeting the RBD and HR1 inhibit binding to host ACE2 receptors and the formation of the fusion core. Other peptides target proteases, such as TMPRSS2 and cathepsin L, to prevent the cleavage of the S protein. However, research has largely ignored peptides targeting the S1/S2 cleavage site. In this study, bioinformatics was used to investigate the binding of the S1/S2 cleavage site to host proteases, including furin, trypsin, TMPRSS2, matriptase, cathepsin B, and cathepsin L. Peptides targeting the S1/S2 site were designed by identifying binding residues. Peptides were docked to the S1/S2 site using HADDOCK (High-Ambiguity-Driven protein–protein DOCKing). Nine peptides with the lowest HADDOCK scores and strong binding affinities were selected, which was followed by molecular dynamics simulations (MDSs) for further investigation. Among these peptides, BR582 and BR599 stand out. They exhibited relatively high interaction energies with the S protein at −1004.769 ± 21.2 kJ/mol and −1040.334 ± 24.1 kJ/mol, respectively. It is noteworthy that the binding of these peptides to the S protein remained stable during the MDSs. In conclusion, this research highlights the potential of peptides targeting the S1/S2 cleavage site as a means to prevent SARS-CoV-2 from entering cells, and contributes to the development of therapeutic interventions against COVID-19.https://www.mdpi.com/1999-4915/15/9/1930SARS-CoV-2S1/S2 cleavage sitepeptidesHADDOCKmolecular dynamics simulation
spellingShingle Chian Ho
Wan Fahmi Wan Mohamad Nazarie
Ping-Chin Lee
An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
Viruses
SARS-CoV-2
S1/S2 cleavage site
peptides
HADDOCK
molecular dynamics simulation
title An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
title_full An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
title_fullStr An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
title_full_unstemmed An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
title_short An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
title_sort in silico design of peptides targeting the s1 s2 cleavage site of the sars cov 2 spike protein
topic SARS-CoV-2
S1/S2 cleavage site
peptides
HADDOCK
molecular dynamics simulation
url https://www.mdpi.com/1999-4915/15/9/1930
work_keys_str_mv AT chianho aninsilicodesignofpeptidestargetingthes1s2cleavagesiteofthesarscov2spikeprotein
AT wanfahmiwanmohamadnazarie aninsilicodesignofpeptidestargetingthes1s2cleavagesiteofthesarscov2spikeprotein
AT pingchinlee aninsilicodesignofpeptidestargetingthes1s2cleavagesiteofthesarscov2spikeprotein
AT chianho insilicodesignofpeptidestargetingthes1s2cleavagesiteofthesarscov2spikeprotein
AT wanfahmiwanmohamadnazarie insilicodesignofpeptidestargetingthes1s2cleavagesiteofthesarscov2spikeprotein
AT pingchinlee insilicodesignofpeptidestargetingthes1s2cleavagesiteofthesarscov2spikeprotein